Splenic marginal zone lymphoma
integrative Medicine for SMZL
Comments
-
Not yet. It is my next optiomn if Ruxolitinib (Jakafi) stops working. Being the new class of non-chemo "inhibitor class" drugs, Ibrutinib is generally better tolerated than chemotherapy and is a therapy which targets the malignant cells. From what I hear, it does have its side-effects nonetheless.
0 -
New here. I'm 66. Also dealing with Stage 4 Marginal Zone Non Hodgkin's Lymphoma. Been doing Chemo with Ruxolitinib for a little over a year. They have so many different categories of this cancer. Hard to know what is what.
I also was just diagnosed with Prostrate Cancer. Scheduling 28 days of Radiation starting some time in April. Doing all pre-op testing and procedures now.
Already a Bladder Cancer survivor and have COPD.
All this while still trying to work full time.
Getting a little frustrated, but not showing it to others. Have to put on the happy face and just deal with it.
Just need to get it off my chest.
0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.9K Cancer specific
- 2.8K Anal Cancer
- 446 Bladder Cancer
- 309 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 397 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.4K Kidney Cancer
- 671 Leukemia
- 793 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 237 Multiple Myeloma
- 7.1K Ovarian Cancer
- 61 Pancreatic Cancer
- 487 Peritoneal Cancer
- 5.5K Prostate Cancer
- 1.2K Rare and Other Cancers
- 539 Sarcoma
- 731 Skin Cancer
- 653 Stomach Cancer
- 191 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards